Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
19.19
+0.64 (3.45%)
Sep 5, 2025, 3:04 PM CST
SHE:300601 Revenue
Shenzhen Kangtai Biological Products had revenue of 746.86M CNY in the quarter ending June 30, 2025, a decrease of -0.47%. This brings the company's revenue in the last twelve months to 2.84B, down -3.64% year-over-year. In the year 2024, Shenzhen Kangtai Biological Products had annual revenue of 2.65B, down -23.75%.
Revenue (ttm)
2.84B
Revenue Growth
-3.64%
P/S Ratio
7.54
Revenue / Employee
1.49M
Employees
1,913
Market Cap
21.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.65B | -825.72M | -23.75% |
Dec 31, 2023 | 3.48B | 320.04M | 10.14% |
Jan 1, 2023 | 3.16B | -494.69M | -13.55% |
Jan 1, 2022 | 3.65B | 1.39B | 61.51% |
Dec 31, 2020 | 2.26B | 317.85M | 16.36% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Shanghai United Imaging Healthcare | 10.98B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |